Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Industry sector: Medical
Sector classification: Surgical & medical instruments
Deep Learning based analysis and prediction model for Boston Scientific Corporation (BSX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 30, 2015.
Market data for BSX model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for BSX.
Model is being retrained on a daily basis.
|% Held by Insiders||0.73%|
|% Held by Institutions||90.98%|
|EPS (last reported FY)||$1.26|
|EPS (last reported Q)||$0.33|
|EPS, estimated (last reported Q)||$0.31|
|Total revenues||$9 B|
|Net income||$0 B|